We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Cellphone-Based Microscope Helps Treat River Blindness

By MedImaging International staff writers
Posted on 21 Nov 2017
Print article
Image: An adult Loa loa worm (Photo courtesy of UC Berkeley).
Image: An adult Loa loa worm (Photo courtesy of UC Berkeley).
A smartphone-connected microscope uses video technology to automatically detect and quantify infection by parasitic worms in a drop of blood, according to a new study.

Developed at the University of California (UC, Berkeley, USA), LoaScope technology is a field-friendly diagnostic tool that turns the camera of a mobile phone or tablet computer into a high-quality light microscope. The technology has applications that incude infectious disease diagnosis, ocean microorganism surveys, eye disease detection diagnosis, and classroom education. For the study, the LoaScope was used to identify persons with Loa loa microfilariae in their peripheral blood with a density greater than 20,000 microfilariae per milliliter of blood.

The quantification was necessary to identify persons if patients suffering from river blindness are also infected with Loa loa before receiving treatment. River blindness is caused by another parasitic worm, Onchocerca volvulus, which is transmitted to humans through bites of infected black flies; left untreated, infections in the eye can lead to blindness. The medication to treat the infection, ivermectin, can be fatal when the patient also has high blood levels of Loa loa. From August through October 2015, 16,259 persons five years of age or older were tested for Loa loa.

The results showed that among study participants who underwent testing, 95.5% received ivermectin, 2.1% were excluded from ivermectin distribution because of an L. loa microfilarial density above the risk threshold, and 2.4% were excluded because of pregnancy or illness. No serious adverse events were observed, and non-serious adverse events were recorded in 934 participants, most of whom (67.5%) had no detectable L. loa microfilariae. The study was published on November 8, 2017, in the New England Journal of Medicine (NEJM).

“This is not just a step forward for efforts to eliminate river blindness, but it is a demonstration that mobile microscopy, based on a mobile phone, can safely and effectively expand access to healthcare,” said study co-author bioengineering professor Daniel Fletcher, PhD. “This work sets the stage for expanding the use of mobile microscopy to improve diagnosis and treatment of other diseases, both in low-resource areas and eventually back in the United States.”

Ivermectin is effective against many different types of parasites, such as head lice, scabies, river blindness, strongyloidiasis, and lymphatic filariasis, among others. It has an added bonus of helping keep malaria-carrying mosquito populations at bay. Discovered in 1975, Ivermectin works by causing an increase in the permeability of the cell membrane, resulting in paralysis and death of the parasite.

Related Links:
University of California

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Software
UltraExtend NX
New
C-Arm with FPD
Digiscan V20 / V30
New
Breast Imaging Workstation
SecurView

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.